MIDAS is the first large.

MIDAS is significant since it shows for the very first time that taking 900 mg of algal DHA daily may have a very meaningful and important impact on cognitive function in the maturing population. We’ve known for a long time based on the strong body of epidemiological study that DHA may play an important role in cognitive function, particularly in the aging human population, stated. Dr. Karin Yurko-Mauro, associate director of clinical analysis for Martek and project lead of MIDAS. With MIDAS, we now have clinical evidence to point that 900 mg of algal DHA enhances memory and learning in maturing adults. .. Algal DHA improves memory space function in healthy ageing adults: MIDAS The Memory space Improvement with Docosahexaenoic acid Study published online this week in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association showed that algal DHA improved memory function in healthy aging adults, providing an advantage roughly equivalent to having the memory and learning abilities of someone 3 years younger.ARIAD believes that Iclusig is an important medicine for sufferers with resistant or intolerant Philadelphia-positive leukemias and is usually actively dealing with the FDA on activities to achieve the resumption of advertising of Iclusig. Today's Conference Call in 9:00 a.m. ET ARIAD management will host a conference call and webcast to go over these actions today, October 31 at 9:00 a.m. ET. The live webcast could be accessed at the investor relations section of the Company's website at The decision could be accessed by dialing 800-510-0146 or +1 617-614-3449 and offering the participant code 74034136.